Abstract
ObjectivesWe examined the efficacy and safety of combining anlotinib with albumin-bound)paclitaxel (ab-paclitaxel) in patients with recurrent,platinum-resistant ovarian or peritoneal carcinoma.MethodsIn this study,44 patients progressing within 6 months after prior platinum-based...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
